2024/01/25 17:32:23 | |
---|---|
Price | |
34.0277 CHF | |
Difference | -2.36% (-0.82) |
ISIN | CH0011432447 |
Symbol | BSLN |
Exchange | London Stock Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 520 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 45.05 CHF (1,000) |
Ask (Ask size) | 47.35 CHF (1,000) |
Open | 34.0277 CHF |
High | 34.0277 CHF |
Low | 34.0277 CHF |
Close (prev. day) | 34.8486 CHF |
VWAP | 34.02772 CHF |
Volume (pcs) | 6,855 |
Trading volume | 233,260.02 |
Number of trades | 1 |
Last size | 6,855 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/03/26 |
![]() |
Global Strategy 2Q 2024 |
![]() |
2024/02/22 |
![]() |
Global Equity Ratings |
![]() |
2024/01/25 17:32:23 | |
---|---|
Price | |
34.0277 CHF | |
Difference | -2.36% (-0.82) |
ISIN | CH0011432447 |
Symbol | BSLN |
Exchange | London Stock Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 520 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 45.05 CHF (1,000) |
Ask (Ask size) | 47.35 CHF (1,000) |
Open | 34.0277 CHF |
High | 34.0277 CHF |
Low | 34.0277 CHF |
Close (prev. day) | 34.8486 CHF |
VWAP | 34.02772 CHF |
Volume (pcs) | 6,855 |
Trading volume | 233,260.02 |
Number of trades | 1 |
Last size | 6,855 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.75 | 0.56 | 0.88 |
Volatility | 12.06 | 15.04 | 60.60 |
Ø price 5 days | Ø volume 5 days (pcs.) | - CHF (267) |
Ø price 30 days | Ø volume 30 days (pcs.) | - CHF (45) |
Ø price 100 days | Ø volume 100 days (pcs.) | 34.4381 CHF (146) |
Ø price 250 days | Ø volume 250 days (pcs.) | 37.1408 CHF (712) |
YTD High | date | 34.9500 CHF (2024/01/24) |
YTD Low | date | 34.0277 CHF (2024/01/25) |
52 Weeks High | date | 46.6000 CHF (2023/09/14) |
52 Weeks Low | date | 34.0277 CHF (2024/01/25) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Stuttgart | 2019/06/28 | 17:19 | 32.60 EUR | 0.02 | 8 |
SIX Swiss Exchange | 2024/07/17 | 17:30 | 42.00 CHF | 1.12 | 324 |
London Stock Exchange | 2024/01/25 | 17:32 | 34.0277 CHF | 0.23 | 1 |
Frankfurt | 2019/06/28 | 15:43 | 32.28 EUR | 0.00 | 3 |
FINRA other OTC Issues | 2024/07/17 | 20:00 | 47.00 USD | 0.00 | 1 |
BASILEA PHARMACEUTICA AG |
- - |
Hegenheimermattweg 167b - 4123 Allschwil |
Telefon: +41-61-606-11-11 |
Fax: + |
E-mail: info@basilea.com |
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland. |
David Veitch | Chairman of Managing Board |
Gerrit Hauck | Member of Executive Committee |
Laurenz Kellenberger | Member of Executive Committee |
Marc Engelhardt | Member of Executive Committee |
Adesh Kaul | Member of Executive Committee |
Alf Gunnar Martin Nicklasson | Member of the administrative board |
Carole Sable | Member of the administrative board |
Nicole Onetto | Member of the administrative board |
Thomas Werner | Member of the administrative board |
Leonard Kruimer | Member of the administrative board |
Domenico Scala | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer